Abstract
Osteoporosis associated with cystic fibrosis is becoming more important as the life expectancy of patients continues to improve. This study was done to determine the prevalence of osteoporosis and osteopenia in CF patients and to identify risk factors. We reviewed the medical charts of 103 adults and adolescents with Cystic Fibrosis who had undergone a dual energy X-ray absorptiometry (DEXA) scan to measure the bone mineral content of the lumbar spine (L1–L4). Disease severity was assessed by lung function and body mass index (BMI) was calculated from weight and height at the time of the DEXA. None of the patients were being treated for low BMD. Random blood samples were analyzed for biochemical markers. The relationship between all these variables and BMD measurements was analyzed. Of 103 patients, ten (9.7 %) patients (9 males, 1 female) were diagnosed with osteoporosis. An additional 36 (35 %) patients (26 males, 10 females) were identified as having osteopenia. BMI, gender, weight, lung functions (FVC, FEV1, and FEF 25–75), and alkaline phosphatase, and 25-OH vitamin D levels were significantly correlated with Z-scores (p < 0.05). Stepwise linear regression revealed that a low Z-score was best predicted with low FEV1, male gender, low weight, and low 25-OH vitamin D levels (p < 0.05) for each variable. Osteopenia and osteoporosis are common in adults with CF, especially in male patients and in patients with low lung function, body weight, and 25-OH vitamin D levels.
Similar content being viewed by others
Abbreviations
- BMI:
-
Body mass index
- CF:
-
Cystic fibrosis
- DEXA:
-
Dual energy X-ray absorptiometry
- FEV1:
-
Forced expiratory volume in one second
References
Cystic Fibrosis Foundation Patient Registry Annual Data Report 2011 (2012) Bethesda, Maryland; Cystic Fibrosis Foundation
Grey AB, Ames RW, Matthews RD, Reid IR (1993) Bone mineral density and body composition in adult patients with cystic fibrosis. Thorax 48:589–593
Bachrach LK, Loutit CW, Moss RB (1994) Osteopenia in adults with cystic fibrosis. Am J Med 96:27–34
Henderson RC, Madsen CD (1996) Bone density in children and adolescents with cystic fibrosis. J Pediatr 128:28–34
Bhudhikanok GS, Wang MC, Marcus R, Harkins A, Moss RB, Bachrach LK (1998) Bone acquisition and loss in children and adults with cystic fibrosis: a longitudinal study. J Pediatr 133:18–27
Haworth CS, Selby PL, Webb AK, Dodd ME, Musson H, McNiven R, Economou G, Horrocks AW, Freemont AJ, Mawer EB, Adams JE (1999) Low bone mineral density in adults with cystic fibrosis. Thorax 54:961–967
Conway SP, Morton AM, Oldroyd B, Truscott JG, White H, Smith AH, Haigh I (2000) Osteoporosis and osteopenia in adults and adolescents with cystic fibrosis: prevalence and associated factors. Thorax 55:798–804
Legroux-Gérot I et al (2012) Bone loss in adults with cystic fibrosis: prevalence, associated factors, and usefulness of biological markers. Joint Bone Spine 79:73–77
Guide to bone health and disease in cystic fibrosis: consensus conference report (2002) Cystic Fibrosis Foundation: vol x, section 4, pp 1–28
Laursen EM, Molgaard C, Michaelson KF, Koch C, Muller J (1999) Bone mineral status in 134 patients with cystic fibrosis. Arch Dis Child 81:235–240
Donovan DS, Papadopoulas A, Staron RB, Addesso V, Schulman L, McGregor C, Cosman F, Lindsay RL, Shane E (1998) Bone mass and vitamin D deficiency in adults with advanced cystic fibrosis lung disease. Am J Respir Crit Care Med 157:1892–1899
Buntain HM, Greer RM, Schluter PJ, Wong JH, Batch JA, Lewindon PJ, Powell E, Wainwright CE, Bell SC (2004) Bone mineral density in Australian children, adolescents and adults with cystic fibrosis: a controlled cross sectional study. Thorax 59:149–155
Aris RM, Renner JB, Winders AD, Buell HE, Riggs DB, Lester GE, Ontjes DA (1998) Increased rate of fractures and severe kyphosis: sequelae of living into adulthood with cystic fibrosis. Ann Intern Med 128:186–193
Sin DD, Man JP, Man SF (2003) The risk of osteoporosis in Caucasian men and women with obstructive airways disease. Am J Med 114:10–14
de Vries F, van Staa TP, Bracke MS, Cooper C, Leufkens HG, Lammers JW (2005) Severity of obstructive airway disease and risk of osteoporotic fracture. Eur Respir J 25:879–884
Lekamwasam S, Trivedi DP, Khaw KT (2002) An association between respiratory function and bone mineral density in women from the general community: a cross sectional study. Osteoporos Int 13:710–715
van Staa TP, Leufkens HG, Cooper C (2003) Inhaled corticosteroids and hip fracture: disease or drugs? Am J Respir Crit Care Med 168:128–129
Katsura H, Kida K (2002) A comparison of bone mineral density in elderly female patients with COPD and bronchial asthma. Chest 122:1949–1955
Aris RM, Ontjes DA, Buell HE, Blackwood AD, Lark RK, Caminiti M, Brown SA, Renner JB, Chalermskulrat W, Lester GE (2002) Abnormal bone turnover in cystic fibrosis adults. Osteoporosis Int 13(2):151–157
Gibbens DT, Gilsanz V, Boechat MI, Dufer D, Carlson ME, Wang CI (1988) Osteoporosis in cystic fibrosis. J Pediatr 113(2):295–300
Dodge JA, Morison S, Lewis PA et al (1997) Incidence, population, and survival of cystic fibrosis in the UK, 1968–95. Arch Dis Child 77:493–496
Acknowledgments
This study was not funded by any grant.
Conflict of interest
No potential conflict of interest exists with any companies or organizations whose products and services may be discussed in this article. All authors have no conflicts of interest.
Author information
Authors and Affiliations
Corresponding author
Appendix
Appendix
Definition of terms and criteria
Osteoporosis: A disease characterized by low bone mass and structural deterioration of bone tissue, leading to bone loss and to an increased risk of bone fractures.
Osteopenia: Low bone mass for age; a clinically significant decrease in bone mass compared to expected values adjusted for age and gender.
WHO classification for osteoporosis:
Normal—Z-score greater than −1.0,
Osteopenia—Z-score between −1.0 and −2.49,
Osteoporosis—Z-score of −2.5 or less.
Body mass index (BMI): A ratio that indicates appropriate weight for height. Weight in kg divided by height in meters squared.
Dual energy X-ray absorptiometry (DEXA): Measures bone mineral content of regional bones and whole body (Bone mineral density gm/cm2). Results are influenced by and referenced to patient’s age, height, weight, and Tanner stage.
25-hydroxy vitamin D (25-OH vitamin D): CFF Bone Health Consensus Report (2002) recommends targeting 25-hydroxy vitamin D levels above 30 ng/ml in the CF population [9].
Z-scores: The number of standard deviations (SD) that a BMD measurement is from the mean of an age- and gender-matched control population.
About this article
Cite this article
Sheikh, S., Gemma, S. & Patel, A. Factors associated with low bone mineral density in patients with cystic fibrosis. J Bone Miner Metab 33, 180–185 (2015). https://doi.org/10.1007/s00774-014-0572-z
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00774-014-0572-z